PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIO vs. TMO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BIO and TMO is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

BIO vs. TMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
16.41%
2.13%
BIO
TMO

Key characteristics

Sharpe Ratio

BIO:

0.29

TMO:

0.12

Sortino Ratio

BIO:

0.65

TMO:

0.31

Omega Ratio

BIO:

1.08

TMO:

1.04

Calmar Ratio

BIO:

0.14

TMO:

0.10

Martin Ratio

BIO:

0.83

TMO:

0.31

Ulcer Index

BIO:

11.64%

TMO:

7.83%

Daily Std Dev

BIO:

33.12%

TMO:

19.92%

Max Drawdown

BIO:

-76.26%

TMO:

-71.16%

Current Drawdown

BIO:

-57.41%

TMO:

-16.11%

Fundamentals

Market Cap

BIO:

$9.55B

TMO:

$208.44B

EPS

BIO:

-$28.07

TMO:

$15.97

PEG Ratio

BIO:

1.19

TMO:

2.10

Total Revenue (TTM)

BIO:

$1.90B

TMO:

$31.48B

Gross Profit (TTM)

BIO:

$1.04B

TMO:

$12.89B

EBITDA (TTM)

BIO:

-$1.25B

TMO:

$8.44B

Returns By Period

The year-to-date returns for both stocks are quite close, with BIO having a 7.06% return and TMO slightly lower at 6.78%. Over the past 10 years, BIO has underperformed TMO with an annualized return of 11.63%, while TMO has yielded a comparatively higher 16.46% annualized return.


BIO

YTD

7.06%

1M

4.59%

6M

16.41%

1Y

10.40%

5Y*

-1.36%

10Y*

11.63%

TMO

YTD

6.78%

1M

5.43%

6M

2.13%

1Y

2.34%

5Y*

10.94%

10Y*

16.46%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIO vs. TMO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIO
The Risk-Adjusted Performance Rank of BIO is 5757
Overall Rank
The Sharpe Ratio Rank of BIO is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of BIO is 5454
Sortino Ratio Rank
The Omega Ratio Rank of BIO is 5353
Omega Ratio Rank
The Calmar Ratio Rank of BIO is 5656
Calmar Ratio Rank
The Martin Ratio Rank of BIO is 5959
Martin Ratio Rank

TMO
The Risk-Adjusted Performance Rank of TMO is 5050
Overall Rank
The Sharpe Ratio Rank of TMO is 5555
Sharpe Ratio Rank
The Sortino Ratio Rank of TMO is 4444
Sortino Ratio Rank
The Omega Ratio Rank of TMO is 4343
Omega Ratio Rank
The Calmar Ratio Rank of TMO is 5555
Calmar Ratio Rank
The Martin Ratio Rank of TMO is 5454
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIO vs. TMO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIO, currently valued at 0.29, compared to the broader market-2.000.002.000.290.12
The chart of Sortino ratio for BIO, currently valued at 0.65, compared to the broader market-4.00-2.000.002.004.000.650.31
The chart of Omega ratio for BIO, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.04
The chart of Calmar ratio for BIO, currently valued at 0.14, compared to the broader market0.002.004.006.000.140.10
The chart of Martin ratio for BIO, currently valued at 0.83, compared to the broader market0.0010.0020.000.830.31
BIO
TMO

The current BIO Sharpe Ratio is 0.29, which is higher than the TMO Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of BIO and TMO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
0.29
0.12
BIO
TMO

Dividends

BIO vs. TMO - Dividend Comparison

BIO has not paid dividends to shareholders, while TMO's dividend yield for the trailing twelve months is around 0.28%.


TTM20242023202220212020201920182017201620152014
BIO
Bio-Rad Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TMO
Thermo Fisher Scientific Inc.
0.28%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%0.48%

Drawdowns

BIO vs. TMO - Drawdown Comparison

The maximum BIO drawdown since its inception was -76.26%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for BIO and TMO. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%AugustSeptemberOctoberNovemberDecember2025
-57.41%
-16.11%
BIO
TMO

Volatility

BIO vs. TMO - Volatility Comparison

Bio-Rad Laboratories, Inc. (BIO) has a higher volatility of 7.53% compared to Thermo Fisher Scientific Inc. (TMO) at 5.29%. This indicates that BIO's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
7.53%
5.29%
BIO
TMO

Financials

BIO vs. TMO - Financials Comparison

This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab